SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-298481
Filing Date
2022-12-05
Accepted
2022-12-05 16:34:07
Documents
13
Period of Report
2022-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d432046d8k.htm   iXBRL 8-K 38775
2 EX-4.1 d432046dex41.htm EX-4.1 12542
  Complete submission text file 0001193125-22-298481.txt   178475

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20221202.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20221202_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20221202_pre.xml EX-101.PRE 11263
7 EXTRACTED XBRL INSTANCE DOCUMENT d432046d8k_htm.xml XML 3368
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 221445416
SIC: 8090 Services-Misc Health & Allied Services, NEC